Home » Topics » BioWorld Science

BioWorld Science
RSS

ViiV Healthcare patents new antivirals for HIV-1 infection

May 21, 2020

Shorter telomere length tied to moderate to severe COPD

May 21, 2020

SGT-001 data support potential for treating Duchenne muscular dystrophy

May 21, 2020

The world according to GARP

May 21, 2020

FDA approves Lynparza for HRR gene-mutated castration-resistant prostate cancer

May 20, 2020

Aldeyra advances compounds with potential utility for COVID-19

May 20, 2020

FDA clears IND for phase II study of Atea's AT-527 for COVID-19

May 20, 2020

Mini-dystrophin gene therapy PF-06939926 trial results boost phase III planning

May 20, 2020

Adjuvance receives NIAID funding to evaluate vaccine adjuvant with SARS-CoV2 antigen

May 20, 2020

Novavax studies SARS-CoV-2 recombinant spike protein nanoparticle vaccine in healthy subjects

May 20, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...